DK1041985T3 - Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme - Google Patents

Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme

Info

Publication number
DK1041985T3
DK1041985T3 DK98963829T DK98963829T DK1041985T3 DK 1041985 T3 DK1041985 T3 DK 1041985T3 DK 98963829 T DK98963829 T DK 98963829T DK 98963829 T DK98963829 T DK 98963829T DK 1041985 T3 DK1041985 T3 DK 1041985T3
Authority
DK
Denmark
Prior art keywords
prophylactic
disorders
treatment
combination
antineoplastic drugs
Prior art date
Application number
DK98963829T
Other languages
Danish (da)
English (en)
Inventor
Ronald J Doll
Ashit Ganguly
David L Cutler
Walter R Bishop
Joseph J Catino
Viyyoor Girijavallabhan
Paul Kirschmeier
Ming Liu
Loretta L Nielsen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1041985(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK1041985T3 publication Critical patent/DK1041985T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98963829T 1997-12-22 1998-12-21 Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme DK1041985T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99602797A 1997-12-22 1997-12-22
US14352998A 1998-08-28 1998-08-28
US18196998A 1998-10-29 1998-10-29

Publications (1)

Publication Number Publication Date
DK1041985T3 true DK1041985T3 (da) 2006-06-19

Family

ID=27385940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98963829T DK1041985T3 (da) 1997-12-22 1998-12-21 Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme

Country Status (25)

Country Link
EP (1) EP1041985B1 (https=)
JP (1) JP4502503B2 (https=)
KR (1) KR100700907B1 (https=)
CN (1) CN1129431C (https=)
AR (1) AR017440A1 (https=)
AT (1) ATE317697T1 (https=)
AU (1) AU756762B2 (https=)
BR (1) BR9814419A (https=)
CA (1) CA2315693C (https=)
CL (1) CL2007001889A1 (https=)
CO (1) CO5080764A1 (https=)
CZ (1) CZ298511B6 (https=)
DE (1) DE69833509T2 (https=)
DK (1) DK1041985T3 (https=)
ES (1) ES2255196T3 (https=)
HU (1) HUP0102473A3 (https=)
IL (1) IL136462A0 (https=)
MY (1) MY137303A (https=)
NO (1) NO326832B1 (https=)
NZ (1) NZ504928A (https=)
PE (1) PE20000042A1 (https=)
PT (1) PT1041985E (https=)
SK (1) SK285584B6 (https=)
TW (1) TW581763B (https=)
WO (1) WO1999032114A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (fr) * 1998-12-21 2003-01-17 Aventis Pharma Sa Compositions contenant des inhibiteurs de farnesyle transferase
CZ20021550A3 (cs) * 1999-11-09 2003-02-12 Societe De Conseils De Recherches Et D'application Produkt zahrnující inhibitor transdukce signálů heterotrimerického G proteinu kombinovaný s jiným protirakovinným činidlem pro terapeutické použití v léčbě rakoviny
WO2001045740A2 (en) * 1999-12-22 2001-06-28 The Government Of The United States, Department Of Health And Human Services Compositions and methods for treatment of breast cancer
US20030027808A1 (en) * 2000-02-29 2003-02-06 Palmer Peter Albert Farnesyl protein transferase inhibitor combinations with platinum compounds
EP1261343A2 (en) * 2000-02-29 2002-12-04 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
US20030078281A1 (en) * 2000-02-29 2003-04-24 Rybak Mary Ellen Margaret Farnesyl protein transferase inhibitor combinations with anti-tumor alkylating agents
EP1267871A2 (en) * 2000-02-29 2003-01-02 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
WO2001064196A2 (en) * 2000-02-29 2001-09-07 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with vinca alkaloids
AU2001244167A1 (en) * 2000-02-29 2001-09-12 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
TWI310684B (en) 2000-03-27 2009-06-11 Bristol Myers Squibb Co Synergistic pharmaceutical kits for treating cancer
WO2002056884A2 (en) * 2001-01-22 2002-07-25 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
JP4969016B2 (ja) * 2001-02-15 2012-07-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物
CN1617755A (zh) * 2001-11-30 2005-05-18 先灵公司 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用
CA2468996A1 (en) * 2001-12-03 2003-06-12 Schering Corporation Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
CN105198758A (zh) * 2015-09-22 2015-12-30 湖南大学 一种高纯度(z)-他莫昔酚的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
WO1992011034A1 (en) * 1990-12-18 1992-07-09 The Wellcome Foundation Limited Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
JP2767176B2 (ja) * 1992-12-15 1998-06-18 大塚製薬株式会社 抗癌剤
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
DE69635114T2 (de) * 1995-08-09 2006-03-02 Banyu Pharmaceutical Co., Ltd. Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
IL125062A (en) * 1995-12-22 2003-11-23 Schering Corp Tricyclic amides and pharmaceutical compositions containing them for inhibition of g-protein function and for treatment of proliferative diseases
CN1304058C (zh) * 1996-03-12 2007-03-14 Pg－Txl有限公司 水溶性紫杉醇产品
EP0959883A4 (en) * 1996-04-03 2001-05-09 Merck & Co Inc INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
US20020034725A1 (en) * 1996-04-15 2002-03-21 W. Gillies Mckenna Sensitization of cells to radiation and and chemotherapy
CA2251955A1 (en) * 1996-04-18 1997-10-23 Nancy E. Kohl A method of treating cancer
EP0934270A1 (en) * 1996-05-30 1999-08-11 Merck & Co., Inc. A method of treating cancer
US6337992B1 (en) * 1997-01-29 2002-01-08 Philips Medical Systems Technologies Ltd. Predictive bolus tracking
IL131447A0 (en) * 1997-02-18 2001-01-28 Canji Inc Combined tumor supressor gene therapy and chemotherapy in the treatment of neoplasms

Also Published As

Publication number Publication date
CO5080764A1 (es) 2001-09-25
CZ20002236A3 (cs) 2001-04-11
DE69833509D1 (de) 2006-04-20
CN1129431C (zh) 2003-12-03
IL136462A0 (en) 2001-06-14
KR100700907B1 (ko) 2007-03-29
CA2315693C (en) 2010-11-30
JP2001526224A (ja) 2001-12-18
DE69833509T2 (de) 2006-10-26
PT1041985E (pt) 2006-07-31
HUP0102473A2 (hu) 2002-01-28
ES2255196T3 (es) 2006-06-16
TW581763B (en) 2004-04-01
EP1041985A1 (en) 2000-10-11
JP4502503B2 (ja) 2010-07-14
SK8982000A3 (en) 2001-04-09
NO20003229L (no) 2000-08-22
NZ504928A (en) 2004-12-24
NO326832B1 (no) 2009-02-23
NO20003229D0 (no) 2000-06-21
ATE317697T1 (de) 2006-03-15
EP1041985B1 (en) 2006-02-15
WO1999032114A1 (en) 1999-07-01
CN1284875A (zh) 2001-02-21
MY137303A (en) 2009-01-30
AU756762B2 (en) 2003-01-23
HUP0102473A3 (en) 2003-07-28
AR017440A1 (es) 2001-09-05
AU1907299A (en) 1999-07-12
BR9814419A (pt) 2000-10-10
CA2315693A1 (en) 1999-07-01
SK285584B6 (sk) 2007-04-05
PE20000042A1 (es) 2000-02-17
CZ298511B6 (cs) 2007-10-24
CL2007001889A1 (es) 2008-01-11
KR20010033452A (ko) 2001-04-25

Similar Documents

Publication Publication Date Title
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
DK0830864T3 (da) Kombinationsbehandling til behandling af psykoser
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
IL155795A0 (en) Combination of drugs (e.g. chlorpromazine and pentamidine) for the treatment of neoplastic disorders
IT1296619B1 (it) Procedimento per il trattamento di protesi a struttura aperturata e relativi dispositivi.
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1032408T3 (da) Galenisk præparat til forebyggelse og behandling af leverkarcinom
DK1021194T3 (da) Ny forbedret formulering til behandling af osteoporose
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
NO20003065L (no) Kombinasjon for effektiv behandling av impotens
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20005179D0 (no) Medikament behandling
DK199800837A (da) Anlæg til behandling af emner
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK1032559T3 (da) Aminoalkylphenolderivater til behandling af depression og hukommelsessvigt
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser